NCT05277051 2025-12-19First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Recruiting158 enrolled
NCT03307785 2025-11-25Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042Tesaro, Inc.Phase 1 Completed60 enrolled 91 charts